Translate
Sumitomo Pharma Co.ltd.
About
1,509.50JPY-61.00 -3.88%
Closed • Updated at 10:50 GMT+00:00Market Cap$4.26B
P/E Ratio5.61
Volume6.19M
Beta0.90
RSI34.76
Gross Margin56.67%
Sumitomo Pharma Co.ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 23 2026
Sumitomo Pharma America Announces that its Investigational Therapy DSP-3077 Has Received FDA Orphan Drug Designation for the Treatment of Retinitis Pigmentosa
Dec 8 2025
Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition
Nov 3 2025
Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting
Oct 7 2025
Knight Therapeutics Announces Relaunch of ORGOVYX® in Canada
Oct 7 2025
Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada
Recent Videos
【特集】住友ファーマ19％暴落の衝撃｜1400億円増資と15％希薄化が招いた市場の拒絶反応を分析
May 17, 2026
【住友ファーマ4506】最新決算をガチ分析！今は“買い”なんか“逃げ”なんか？
May 13, 2026
2026/5/13 住友ファーマ株価株式投資
May 13, 2026
【デイトレ】住友ファーマがなかなか上がらない！ ＠デイトレ＠5/7＠住友ファーマ＠木村化工機＠任天堂＠EDP
May 07, 2026